Rebus Holdings, Inc. (RBSH)

USD 0.0

(0.0%)

Total Debt Summary of Rebus Holdings, Inc.

  • Rebus Holdings, Inc.'s latest annual total debt in 2022 was 310 Thousand USD , down -39.69% from previous year.
  • Rebus Holdings, Inc.'s latest quarterly total debt in 2023 Q1 was 310 Thousand USD , down 0.0% from previous quarter.
  • Rebus Holdings, Inc. reported annual total debt of 514 Thousand USD in 2021, down -72.63% from previous year.
  • Rebus Holdings, Inc. reported annual total debt of 1.87 Million USD in 2020, down -33.55% from previous year.
  • Rebus Holdings, Inc. reported quarterly total debt of 310 Thousand USD for 2023 Q1, down 0.0% from previous quarter.
  • Rebus Holdings, Inc. reported quarterly total debt of 310 Thousand USD for 2022 FY, down -39.69% from previous quarter.

Annual Total Debt Chart of Rebus Holdings, Inc. (2022 - 2007)

Historical Annual Total Debt of Rebus Holdings, Inc. (2022 - 2007)

Year Total Debt Total Debt Growth
2022 310 Thousand USD -39.69%
2021 514 Thousand USD -72.63%
2020 1.87 Million USD -33.55%
2019 2.82 Million USD 8.69%
2018 2.6 Million USD 5.01%
2017 2.47 Million USD 0.0%
2016 - USD 0.0%
2015 - USD -100.0%
2014 105 Thousand USD 0.0%
2013 105 Thousand USD 0.0%
2012 105 Thousand USD 0.0%
2011 105 Thousand USD 0.0%
2010 - USD -100.0%
2009 70 Thousand USD -54.11%
2008 152.55 Thousand USD 0.0%
2007 - USD 0.0%

Peer Total Debt Comparison of Rebus Holdings, Inc.

Name Total Debt Total Debt Difference
Eiger BioPharmaceuticals, Inc. 41.2 Million USD 99.248%
Nanobac Pharmaceuticals, Incorporated 4.12 Million USD 92.479%
SQZ Biotechnologies Company 27.47 Million USD 98.872%
Evofem Biosciences, Inc. 43.37 Million USD 99.285%
Santhera Pharmaceuticals Holding AG 29.76 Million USD 98.959%
Mesoblast Limited 118.7 Million USD 99.739%
Propanc Biopharma, Inc. 948.27 Thousand USD 67.309%
Genus plc 233.1 Million USD 99.867%
VioQuest Pharmaceuticals, Inc. 2.93 Million USD 89.421%
CNBX Pharmaceuticals Inc. 1.34 Million USD 76.927%
Marizyme, Inc. 18.71 Million USD 98.344%
ContraFect Corporation 2.88 Million USD 89.24%
Nymox Pharmaceutical Corporation 750 Thousand USD 58.667%
PsyBio Therapeutics Corp. 135.48 Thousand USD -128.804%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
RegeneRx Biopharmaceuticals, Inc. 1.44 Million USD 78.566%
Intellipharmaceutics International Inc. 2.32 Million USD 86.672%
AXIM Biotechnologies, Inc. 5.65 Million USD 94.521%
MultiCell Technologies, Inc. 202.58 USD -152925.965%
Accustem Sciences Inc. - USD -Infinity%
RVL Pharmaceuticals plc 57.48 Million USD 99.461%
EV Biologics, Inc. 1.49 Million USD 79.261%
Q BioMed Inc. 4.1 Million USD 92.457%
Emmaus Life Sciences, Inc. 33.1 Million USD 99.063%
Neon Bloom, Inc. 630.07 Thousand USD 50.8%
Mosaic ImmunoEngineering Inc. 1.22 Million USD 74.763%
Biomind Labs Inc. 735.54 Thousand USD 57.854%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
Pharming Group N.V. 171.54 Million USD 99.819%
Oncotelic Therapeutics, Inc. 12.99 Million USD 97.615%
Skye Bioscience, Inc. 4.61 Million USD 93.283%
Therapeutic Solutions International, Inc. 888.06 Thousand USD 65.093%
THC Farmaceuticals, Inc. 141.51 Thousand USD -119.053%
Arch Therapeutics, Inc. 5.87 Million USD 94.72%
IMV Inc. 28.88 Million USD 98.927%
Acro Biomedical Co., Ltd. 25.71 Thousand USD -1105.335%
Curative Biotechnology, Inc. 2.25 Million USD 86.273%
GB Sciences, Inc. 1.75 Million USD 82.379%
Alpha Cognition Inc. 1.22 Million USD 74.598%
HST Global, Inc. 98.31 Thousand USD -215.3%
CSL Limited 12.18 Billion USD 99.997%
Halberd Corporation 150 Thousand USD -106.667%
Enzolytics Inc. 996.33 Thousand USD 68.886%
Resverlogix Corp. 6.49 Million USD 95.224%
Affymax, Inc. - USD -Infinity%
SYBLEU INC 477.5 Thousand USD 35.079%
Nuo Therapeutics, Inc. 255.59 Thousand USD -21.287%
argenx SE 20 Million USD 98.45%
MetaStat, Inc. - USD -Infinity%
Northwest Biotherapeutics, Inc. 45.56 Million USD 99.32%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
Arno Therapeutics, Inc. - USD -Infinity%
RespireRx Pharmaceuticals Inc. 2.7 Million USD 88.555%
GeneThera, Inc. - USD -Infinity%
Inhibitor Therapeutics, Inc. - USD -Infinity%
AVAX Technologies, Inc. - USD -Infinity%
Zenith Capital Corp. 10.22 Thousand USD -2931.785%
Genscript Biotech Corporation 417.73 Million USD 99.926%
Ember Therapeutics, Inc. 200.61 Thousand USD -54.524%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. 2.39 Million USD 87.071%
WPD Pharmaceuticals Inc. 229.29 Thousand USD -35.199%
American Oriental Bioengineering, Inc. 67.64 Million USD 99.542%
Provectus Biopharmaceuticals, Inc. 3.02 Million USD 89.756%
Adynxx, Inc. - USD -Infinity%
Helix BioMedix, Inc. - USD -Infinity%
GlobeStar Therapeutics Corporation 359.71 Thousand USD 13.819%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
Capstone Therapeutics Corp. 20.32 Million USD 98.475%
Cotinga Pharmaceuticals Inc. 148.65 Thousand USD -108.538%
BioStem Technologies, Inc. 4.71 Million USD 93.42%
ONE Bio Corp. 19.71 Million USD 98.428%
Reve Technologies, Inc. 250.18 Thousand USD -23.91%
Burzynski Research Institute, Inc. - USD -Infinity%
Wesana Health Holdings Inc. 248.72 Thousand USD -24.638%
Agentix Corp. 50 Thousand USD -520.0%
LadRx Corporation 33.6 Thousand USD -822.454%
Cell Source, Inc. 9.25 Million USD 96.65%
ProtoKinetix, Incorporated - USD -Infinity%
Regen BioPharma, Inc. 756.2 Thousand USD 59.006%
Regen BioPharma, Inc. 756.2 Thousand USD 59.006%
NovAccess Global Inc. 2.19 Million USD 85.908%
Endonovo Therapeutics, Inc. 7.07 Million USD 95.617%
Itoco Inc. 228.37 Thousand USD -35.74%
Rasna Therapeutics, Inc. 210.97 Thousand USD -46.937%
Pathfinder Cell Therapy, Inc. 4.98 Million USD 93.779%
Kadimastem Ltd 891.22 Thousand USD 65.216%
Oncology Pharma Inc. - USD -Infinity%
Institute of Biomedical Research Corp. 401.84 Thousand USD 22.857%
CytoDyn Inc. 30.07 Million USD 98.969%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
Mobile Lads Corp. 484.28 Thousand USD 35.988%
NanoSphere Health Sciences Inc. - USD -Infinity%
Qrons Inc. 351.84 Thousand USD 11.894%
Alseres Pharmaceuticals, Inc. 7.81 Million USD 96.036%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
Nascent Biotech, Inc. 122.5 Thousand USD -153.061%
ImmunoCellular Therapeutics, Ltd. 4.73 Million USD 93.453%
International Stem Cell Corporation 4.17 Million USD 92.58%
Bioxytran, Inc. 1.92 Million USD 83.896%
GlobeImmune, Inc. - USD -Infinity%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. 62.41 Thousand USD -396.691%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. 2.18 Million USD 85.786%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. 8.31 Million USD 96.272%
Adhera Therapeutics, Inc. 8.58 Million USD 96.389%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. 1.55 Million USD 80.07%
Innovation Pharmaceuticals Inc. 268 Thousand USD -15.672%
Neutra Corp. 54.15 Thousand USD -472.42%
Windtree Therapeutics, Inc. 1.83 Million USD 83.06%
PureTech Health plc 25.51 Million USD 98.785%
Coeptis Therapeutics, Inc. 1.22 Million USD 74.678%
IXICO plc 472.02 Thousand USD 34.325%
IntelGenx Technologies Corp. 15.5 Million USD 98.0%
Gelesis Holdings, Inc. 62.26 Million USD 99.502%
CSL Limited 12.18 Billion USD 99.997%
Cellectis S.A. 92.77 Million USD 99.666%